GB201313987D0 - Novel immunotherapy against several tumors, such as lung cancer including NSCLC - Google Patents

Novel immunotherapy against several tumors, such as lung cancer including NSCLC

Info

Publication number
GB201313987D0
GB201313987D0 GBGB1313987.8A GB201313987A GB201313987D0 GB 201313987 D0 GB201313987 D0 GB 201313987D0 GB 201313987 A GB201313987 A GB 201313987A GB 201313987 D0 GB201313987 D0 GB 201313987D0
Authority
GB
United Kingdom
Prior art keywords
lung cancer
cancer including
against several
immunotherapy against
several tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1313987.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immatics Biotechnologies GmbH
Original Assignee
Immatics Biotechnologies GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies GmbH filed Critical Immatics Biotechnologies GmbH
Priority to GBGB1313987.8A priority Critical patent/GB201313987D0/en
Publication of GB201313987D0 publication Critical patent/GB201313987D0/en
Priority to TW109124802A priority patent/TWI777198B/en
Priority to TW109124799A priority patent/TWI777196B/en
Priority to TW109124795A priority patent/TWI777194B/en
Priority to TW109124801A priority patent/TWI777197B/en
Priority to TW109124797A priority patent/TWI777195B/en
Priority to TW107123070A priority patent/TWI714869B/en
Priority to TW109124796A priority patent/TWI775117B/en
Priority to TW109124798A priority patent/TWI776192B/en
Priority to TW103126327A priority patent/TWI636065B/en
Priority to TW109124803A priority patent/TWI819228B/en
Priority to PT147501753T priority patent/PT3030255T/en
Priority to HUE18201334A priority patent/HUE057334T2/en
Priority to KR1020207029965A priority patent/KR102213556B1/en
Priority to HRP20211852TT priority patent/HRP20211852T1/en
Priority to DK18201334.2T priority patent/DK3456339T3/en
Priority to MA46798A priority patent/MA46798B1/en
Priority to NZ733168A priority patent/NZ733168A/en
Priority to AU2014304544A priority patent/AU2014304544B2/en
Priority to CN201910287775.4A priority patent/CN110041403B/en
Priority to KR1020207029978A priority patent/KR102213551B1/en
Priority to UAA201600268A priority patent/UA122661C2/en
Priority to LTEP18201334.2T priority patent/LT3456339T/en
Priority to US14/908,078 priority patent/US20160168200A1/en
Priority to PE2018001559A priority patent/PE20181538A1/en
Priority to CA3073394A priority patent/CA3073394A1/en
Priority to KR1020217001136A priority patent/KR102317816B1/en
Priority to SI201431919T priority patent/SI3456339T1/en
Priority to CN201811283000.1A priority patent/CN109748953B/en
Priority to MX2016001426A priority patent/MX2016001426A/en
Priority to KR1020207029977A priority patent/KR102213552B1/en
Priority to KR1020167000976A priority patent/KR102098329B1/en
Priority to CN201480035925.8A priority patent/CN105377290B/en
Priority to EP19202037.8A priority patent/EP3616709A1/en
Priority to EP14750175.3A priority patent/EP3030255B1/en
Priority to CR20200139A priority patent/CR20200139A/en
Priority to PL18201334T priority patent/PL3456339T3/en
Priority to RS20211445A priority patent/RS62602B1/en
Priority to KR1020227010992A priority patent/KR20220045085A/en
Priority to EA201690016A priority patent/EA035362B1/en
Priority to EP19202010.5A priority patent/EP3616707A1/en
Priority to KR1020207018007A priority patent/KR102211542B1/en
Priority to KR1020187026995A priority patent/KR102098327B1/en
Priority to EP19202028.7A priority patent/EP3616708A1/en
Priority to RS20191676A priority patent/RS59861B1/en
Priority to JP2016532350A priority patent/JP2016527293A/en
Priority to DK14750175.3T priority patent/DK3030255T3/en
Priority to CA3020939A priority patent/CA3020939C/en
Priority to HUE14750175A priority patent/HUE047079T2/en
Priority to ES18201334T priority patent/ES2900004T3/en
Priority to NZ714163A priority patent/NZ714163A/en
Priority to BR112016000810A priority patent/BR112016000810A2/en
Priority to SG10202002612PA priority patent/SG10202002612PA/en
Priority to PCT/EP2014/066755 priority patent/WO2015018805A1/en
Priority to SG11201510580UA priority patent/SG11201510580UA/en
Priority to MA38794A priority patent/MA38794B1/en
Priority to SG10201802399WA priority patent/SG10201802399WA/en
Priority to EP19202000.6A priority patent/EP3613427A1/en
Priority to MYPI2015704260A priority patent/MY191939A/en
Priority to CA3073256A priority patent/CA3073256A1/en
Priority to CR20180508A priority patent/CR20180508A/en
Priority to CR20210464A priority patent/CR20210464A/en
Priority to SG10202002608WA priority patent/SG10202002608WA/en
Priority to PL14750175T priority patent/PL3030255T3/en
Priority to CA2912500A priority patent/CA2912500C/en
Priority to SI201431453T priority patent/SI3030255T1/en
Priority to KR1020187026992A priority patent/KR102217680B1/en
Priority to EP19171543.2A priority patent/EP3578196A1/en
Priority to PE2020000409A priority patent/PE20201284A1/en
Priority to EP19202064.2A priority patent/EP3616712A1/en
Priority to EP19202046.9A priority patent/EP3616710A1/en
Priority to EP19202056.8A priority patent/EP3616711A1/en
Priority to KR1020207009472A priority patent/KR102383710B1/en
Priority to PE2015002616A priority patent/PE20160717A1/en
Priority to EP18201334.2A priority patent/EP3456339B1/en
Priority to PT182013342T priority patent/PT3456339T/en
Priority to KR1020207029963A priority patent/KR102213554B1/en
Priority to CN201910287774.XA priority patent/CN110041402B/en
Priority to IL300761A priority patent/IL300761A/en
Priority to LTEP14750175.3T priority patent/LT3030255T/en
Priority to MA42333A priority patent/MA42333A1/en
Priority to ES14750175T priority patent/ES2764406T3/en
Priority to PH12015502638A priority patent/PH12015502638A1/en
Priority to CR20160018A priority patent/CR20160018A/en
Priority to IL280565A priority patent/IL280565B/en
Priority to IL24378816A priority patent/IL243788B/en
Priority to CL2016000227A priority patent/CL2016000227A1/en
Priority to MX2019011621A priority patent/MX2019011621A/en
Priority to MX2018010565A priority patent/MX2018010565A/en
Priority to MX2021001914A priority patent/MX2021001914A/en
Priority to HK16110313.1A priority patent/HK1222121A1/en
Priority to US15/357,838 priority patent/US10071148B2/en
Priority to US15/639,165 priority patent/US20170320913A1/en
Priority to US15/639,058 priority patent/US9943579B2/en
Priority to JP2017145278A priority patent/JP6646017B2/en
Priority to AU2018200389A priority patent/AU2018200389B2/en
Priority to US16/100,858 priority patent/US10160786B1/en
Priority to CL2018002279A priority patent/CL2018002279A1/en
Priority to CL2018002458A priority patent/CL2018002458A1/en
Priority to CL2018002493A priority patent/CL2018002493A1/en
Priority to CL2018002495A priority patent/CL2018002495A1/en
Priority to CL2018002494A priority patent/CL2018002494A1/en
Priority to PH12018501901A priority patent/PH12018501901A1/en
Priority to ARP180102711A priority patent/AR113131A2/en
Priority to IL295031A priority patent/IL295031B2/en
Priority to IL262509A priority patent/IL262509B/en
Priority to US16/274,491 priority patent/US10323065B1/en
Priority to US16/283,540 priority patent/US10316063B1/en
Priority to US16/283,528 priority patent/US10316062B1/en
Priority to US16/369,905 priority patent/US10487116B2/en
Priority to US16/444,693 priority patent/US10479818B2/en
Priority to JP2019144218A priority patent/JP7039044B2/en
Priority to US16/582,957 priority patent/US10793602B2/en
Priority to IL269753A priority patent/IL269753B/en
Priority to US16/599,258 priority patent/US11161880B2/en
Priority to US16/599,207 priority patent/US11161878B2/en
Priority to US16/599,198 priority patent/US11161877B2/en
Priority to US16/599,211 priority patent/US11161879B2/en
Priority to HRP20192262TT priority patent/HRP20192262T1/en
Priority to CY20191101358T priority patent/CY1122453T1/en
Priority to JP2020001438A priority patent/JP7094572B2/en
Priority to PH12020500433A priority patent/PH12020500433A1/en
Priority to AU2020220042A priority patent/AU2020220042B2/en
Priority to AU2020220045A priority patent/AU2020220045B2/en
Priority to AU2020220041A priority patent/AU2020220041B2/en
Priority to AU2020220038A priority patent/AU2020220038B2/en
Priority to AU2020220043A priority patent/AU2020220043B2/en
Priority to AU2020220040A priority patent/AU2020220040B2/en
Priority to AU2020220039A priority patent/AU2020220039B2/en
Priority to AU2020220044A priority patent/AU2020220044B2/en
Priority to US17/238,932 priority patent/US11814446B2/en
Priority to PH12021551208A priority patent/PH12021551208A1/en
Priority to CL2021001794A priority patent/CL2021001794A1/en
Priority to US17/525,023 priority patent/US11866517B2/en
Priority to CY20211101126T priority patent/CY1124950T1/en
Priority to AU2022201167A priority patent/AU2022201167A1/en
Priority to US17/691,576 priority patent/US11939400B2/en
Priority to US17/698,531 priority patent/US11859017B2/en
Priority to US17/698,526 priority patent/US11939401B2/en
Priority to JP2022096317A priority patent/JP2022130482A/en
Ceased legal-status Critical Current

Links

GBGB1313987.8A 2013-08-05 2013-08-05 Novel immunotherapy against several tumors, such as lung cancer including NSCLC Ceased GB201313987D0 (en)

Priority Applications (140)

Application Number Priority Date Filing Date Title
GBGB1313987.8A GB201313987D0 (en) 2013-08-05 2013-08-05 Novel immunotherapy against several tumors, such as lung cancer including NSCLC
TW109124802A TWI777198B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124799A TWI777196B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124795A TWI777194B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124801A TWI777197B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124797A TWI777195B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW107123070A TWI714869B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124796A TWI775117B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124798A TWI776192B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW103126327A TWI636065B (en) 2013-08-05 2014-08-01 Novel peptides, cells and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
TW109124803A TWI819228B (en) 2013-08-05 2014-08-01 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
PT147501753T PT3030255T (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
HUE18201334A HUE057334T2 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
KR1020207029965A KR102213556B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
HRP20211852TT HRP20211852T1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
DK18201334.2T DK3456339T3 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several different tumors, such as lung cancer, including NSCLC
MA46798A MA46798B1 (en) 2013-08-05 2014-08-04 New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer
NZ733168A NZ733168A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2014304544A AU2014304544B2 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including NSCLC
CN201910287775.4A CN110041403B (en) 2013-08-05 2014-08-04 Novel immunotherapy against a variety of tumors, such as lung cancer including NSCLC
KR1020207029978A KR102213551B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
UAA201600268A UA122661C2 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
LTEP18201334.2T LT3456339T (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
US14/908,078 US20160168200A1 (en) 2013-08-05 2014-08-04 Immunotherapy against several tumors, such as lung cancer, including nsclc
PE2018001559A PE20181538A1 (en) 2013-08-05 2014-08-04 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
CA3073394A CA3073394A1 (en) 2013-08-05 2014-08-04 Immunotherapy against several tumors, such as lung cancer, including ns clc
KR1020217001136A KR102317816B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
SI201431919T SI3456339T1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
CN201811283000.1A CN109748953B (en) 2013-08-05 2014-08-04 Novel immunotherapies for the treatment of various tumors (e.g., lung cancer including NSCLC)
MX2016001426A MX2016001426A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc.
KR1020207029977A KR102213552B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
KR1020167000976A KR102098329B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CN201480035925.8A CN105377290B (en) 2013-08-05 2014-08-04 For treating the novel immune therapy of kinds of tumors (for example including the lung cancer including NSCLC)
EP19202037.8A EP3616709A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
EP14750175.3A EP3030255B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CR20200139A CR20200139A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PL18201334T PL3456339T3 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
RS20211445A RS62602B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
KR1020227010992A KR20220045085A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EA201690016A EA035362B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EP19202010.5A EP3616707A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
KR1020207018007A KR102211542B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
KR1020187026995A KR102098327B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EP19202028.7A EP3616708A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
RS20191676A RS59861B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
JP2016532350A JP2016527293A (en) 2013-08-05 2014-08-04 Novel immunotherapy for several types of tumors such as lung cancer including NSCLC
DK14750175.3T DK3030255T3 (en) 2013-08-05 2014-08-04 NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
CA3020939A CA3020939C (en) 2013-08-05 2014-08-04 Immunotherapy against several tumors, such as lung cancer, including nsclc
HUE14750175A HUE047079T2 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
ES18201334T ES2900004T3 (en) 2013-08-05 2014-08-04 New immunotherapy against various tumors such as lung cancer, including non-small cell lung carcinoma (NSCLC)
NZ714163A NZ714163A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
BR112016000810A BR112016000810A2 (en) 2013-08-05 2014-08-04 immunotherapy against various tumors such as lung cancer including cpcnp
SG10202002612PA SG10202002612PA (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PCT/EP2014/066755 WO2015018805A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
SG11201510580UA SG11201510580UA (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MA38794A MA38794B1 (en) 2013-08-05 2014-08-04 New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer
SG10201802399WA SG10201802399WA (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EP19202000.6A EP3613427A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
MYPI2015704260A MY191939A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CA3073256A CA3073256A1 (en) 2013-08-05 2014-08-04 Immunotherapy against several tumors, such as lung cancer, including nsclc
CR20180508A CR20180508A (en) 2013-08-05 2014-08-04 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC) (Divisional 2016-0018)
CR20210464A CR20210464A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
SG10202002608WA SG10202002608WA (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PL14750175T PL3030255T3 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CA2912500A CA2912500C (en) 2013-08-05 2014-08-04 Novel immunotherapeutic peptide derived from a hla class 1 molecule against cancer
SI201431453T SI3030255T1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
KR1020187026992A KR102217680B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EP19171543.2A EP3578196A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PE2020000409A PE20201284A1 (en) 2013-08-05 2014-08-04 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
EP19202064.2A EP3616712A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
EP19202046.9A EP3616710A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
EP19202056.8A EP3616711A1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
KR1020207009472A KR102383710B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PE2015002616A PE20160717A1 (en) 2013-08-05 2014-08-04 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
EP18201334.2A EP3456339B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
PT182013342T PT3456339T (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer including nsclc
KR1020207029963A KR102213554B1 (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CN201910287774.XA CN110041402B (en) 2013-08-05 2014-08-04 Novel immunotherapy against a variety of tumors, such as lung cancer including NSCLC
IL300761A IL300761A (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including NSCLC
LTEP14750175.3T LT3030255T (en) 2013-08-05 2014-08-04 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MA42333A MA42333A1 (en) 2013-08-05 2014-08-04 New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer
ES14750175T ES2764406T3 (en) 2013-08-05 2014-08-04 New immunotherapy against various tumors, such as lung cancer, including NSCLC
PH12015502638A PH12015502638A1 (en) 2013-08-05 2015-11-26 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CR20160018A CR20160018A (en) 2013-08-05 2016-01-08 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC)
IL280565A IL280565B (en) 2013-08-05 2016-01-26 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
IL24378816A IL243788B (en) 2013-08-05 2016-01-26 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CL2016000227A CL2016000227A1 (en) 2013-08-05 2016-01-28 New immunotherapy against various tumors such as lung cancer, including amicrocytic lung carcinoma (nsclc)
MX2019011621A MX2019011621A (en) 2013-08-05 2016-01-29 Novel immunotherapy against several tumors, such as lung cancer, including nsclc.
MX2018010565A MX2018010565A (en) 2013-08-05 2016-01-29 Novel immunotherapy against several tumors, such as lung cancer, including nsclc.
MX2021001914A MX2021001914A (en) 2013-08-05 2016-01-29 Novel immunotherapy against several tumors, such as lung cancer, including nsclc.
HK16110313.1A HK1222121A1 (en) 2013-08-05 2016-08-30 Novel immunotherapy against several tumors, such as lung cancer, including nsclc ( nsclc )
US15/357,838 US10071148B2 (en) 2013-08-05 2016-11-21 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US15/639,165 US20170320913A1 (en) 2013-08-05 2017-06-30 Immunotherapy against several tumors, such as lung cancer, including nsclc
US15/639,058 US9943579B2 (en) 2013-08-05 2017-06-30 Immunotherapy against several tumors, such as lung cancer, including NSCLC
JP2017145278A JP6646017B2 (en) 2013-08-05 2017-07-27 Novel immunotherapy for several tumors such as NSCLC and lung cancer
AU2018200389A AU2018200389B2 (en) 2013-08-05 2018-01-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
US16/100,858 US10160786B1 (en) 2013-08-05 2018-08-10 Immunotherapy against several tumors, such as lung cancer, including NSCLC
CL2018002279A CL2018002279A1 (en) 2013-08-05 2018-08-10 Peptides, nucleic acids and cells for use in cancer immunotherapy (divisional application 201600227)
CL2018002458A CL2018002458A1 (en) 2013-08-05 2018-08-28 Peptides, nucleic acids, expression vectors and cells for use in cancer immunotherapy (divisional application 201600227)
CL2018002493A CL2018002493A1 (en) 2013-08-05 2018-08-31 Peptides, nucleic acids, expression vectors and cells for use in cancer immunotherapy. (divisional application 201600227)
CL2018002495A CL2018002495A1 (en) 2013-08-05 2018-08-31 Peptides, nucleic acids, expression vectors and cells for use in cancer immunotherapy. (divisional application 201600227)
CL2018002494A CL2018002494A1 (en) 2013-08-05 2018-08-31 Peptides, nucleic acids, expression vectors and cells for the use of cancer immunotherapy (divisional application 201600227)
PH12018501901A PH12018501901A1 (en) 2013-08-05 2018-09-06 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
ARP180102711A AR113131A2 (en) 2013-08-05 2018-09-21 IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
IL295031A IL295031B2 (en) 2013-08-05 2018-10-22 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
IL262509A IL262509B (en) 2013-08-05 2018-10-22 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
US16/274,491 US10323065B1 (en) 2013-08-05 2019-02-13 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US16/283,540 US10316063B1 (en) 2013-08-05 2019-02-22 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US16/283,528 US10316062B1 (en) 2013-08-05 2019-02-22 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US16/369,905 US10487116B2 (en) 2013-08-05 2019-03-29 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US16/444,693 US10479818B2 (en) 2013-08-05 2019-06-18 Immunotherapy against several tumors, such as lung cancer, including NSCLC
JP2019144218A JP7039044B2 (en) 2013-08-05 2019-08-06 New immunotherapy for several types of tumors such as NSCLC and lung cancer
US16/582,957 US10793602B2 (en) 2013-08-05 2019-09-25 Immunotherapy against several tumors, such as lung cancer, including NSCLC
IL269753A IL269753B (en) 2013-08-05 2019-10-02 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
US16/599,258 US11161880B2 (en) 2013-08-05 2019-10-11 Immunotherapy against several tumors, such as lung cancer, including NSCLC
US16/599,207 US11161878B2 (en) 2013-08-05 2019-10-11 Immunotherapy against several tumors including lung cancer
US16/599,198 US11161877B2 (en) 2013-08-05 2019-10-11 Immunotherapy against several tumors including lung cancer
US16/599,211 US11161879B2 (en) 2013-08-05 2019-10-11 Immunotherapy against several tumors, such as lung cancer, including NSCLC
HRP20192262TT HRP20192262T1 (en) 2013-08-05 2019-12-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CY20191101358T CY1122453T1 (en) 2013-08-05 2019-12-27 NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER INCLUDING NSCLC
JP2020001438A JP7094572B2 (en) 2013-08-05 2020-01-08 New immunotherapy for several types of tumors such as NSCLC and lung cancer
PH12020500433A PH12020500433A1 (en) 2013-08-05 2020-03-03 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220042A AU2020220042B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220045A AU2020220045B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220041A AU2020220041B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220038A AU2020220038B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220043A AU2020220043B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220040A AU2020220040B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220039A AU2020220039B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
AU2020220044A AU2020220044B2 (en) 2013-08-05 2020-08-17 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
US17/238,932 US11814446B2 (en) 2013-08-05 2021-04-23 Immunotherapy against several tumors including lung cancer
PH12021551208A PH12021551208A1 (en) 2013-08-05 2021-05-26 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CL2021001794A CL2021001794A1 (en) 2013-08-05 2021-07-06 Peptide, nucleic acid, cell, pharmaceutical composition, activated t cell, isolated binding agent, and tcr, for use in cancer immunotherapy; and methods for producing them (divisional of application no. 201600227)
US17/525,023 US11866517B2 (en) 2013-08-05 2021-11-12 Immunotherapy against several tumors including lung cancer
CY20211101126T CY1124950T1 (en) 2013-08-05 2021-12-22 INNOVATIVE IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER INCLUDING SCLC
AU2022201167A AU2022201167A1 (en) 2013-08-05 2022-02-22 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
US17/691,576 US11939400B2 (en) 2013-08-05 2022-03-10 Immunotherapy against several tumors including lung cancer
US17/698,531 US11859017B2 (en) 2013-08-05 2022-03-18 Immunotherapy against several tumors including lung cancer
US17/698,526 US11939401B2 (en) 2013-08-05 2022-03-18 Immunotherapy against several tumors including lung cancer
JP2022096317A JP2022130482A (en) 2013-08-05 2022-06-15 Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1313987.8A GB201313987D0 (en) 2013-08-05 2013-08-05 Novel immunotherapy against several tumors, such as lung cancer including NSCLC

Publications (1)

Publication Number Publication Date
GB201313987D0 true GB201313987D0 (en) 2013-09-18

Family

ID=49224173

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1313987.8A Ceased GB201313987D0 (en) 2013-08-05 2013-08-05 Novel immunotherapy against several tumors, such as lung cancer including NSCLC

Country Status (3)

Country Link
AR (1) AR113131A2 (en)
GB (1) GB201313987D0 (en)
MA (3) MA42333A1 (en)

Also Published As

Publication number Publication date
AR113131A2 (en) 2020-01-29
MA42333A1 (en) 2019-05-31
MA46798B1 (en) 2022-10-31
MA38794B1 (en) 2019-04-30
MA46798A1 (en) 2022-02-28
MA38794A1 (en) 2017-12-29

Similar Documents

Publication Publication Date Title
HK1222121A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc ( nsclc )
IL280565A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
GB201507030D0 (en) Immunotherapy against lung cancers, in particular NSCLC
EP2971284A4 (en) Subtyping lung cancers
EP2968254A4 (en) Methods of treating lung cancer
GB201322725D0 (en) Cancer therapy
HK1220900A1 (en) Cancer therapy
EP2994148B8 (en) Cancer therapy
EP3007756A4 (en) Catheter-assisted tumor treatment
EP3044593A4 (en) Cancer therapy
EP2961412A4 (en) Cancer therapy
EP3015476A4 (en) Tumor biomarker
EP3277325A4 (en) Combination immunotherapy for small cell lung cancer
IL245477B (en) Lung cancer diagnosis
GB201313987D0 (en) Novel immunotherapy against several tumors, such as lung cancer including NSCLC
GB201403297D0 (en) Novel immunotherapy against several tumors, such as lung cancer, including NSCLC
GB201519261D0 (en) Novel Immunotherapeutic treatments for tumours
EP3077812A4 (en) Methods for the prognosis of breast cancer
GB201317213D0 (en) Cancer Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)